コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 for the reduction of immune responses during Shigella infection.
2 e intestine by 24 hours post-intraperitoneal Shigella infection.
3 e; however, adult mice are resistant to oral Shigella infection.
4 protective efficacy against intraperitoneal Shigella infection.
5 p90 host-cell vinculin fragment generated by Shigella infection.
6 is essential to resistance following primary Shigella infection.
7 e interleukin-1beta is cleaved shortly after Shigella infection.
8 tic therapy for children with non-dysenteric Shigella infection.
9 y help identify patients most likely to have Shigella infection.
10 n to be altered during the course of natural Shigella infection.
11 dentified that surface loops of OmpA mediate Shigella infection.
12 lgi-associated ARF/ARL family GTPases during Shigella infection.
13 ProD was associated with Cryptosporidium and Shigella infections.
14 Ciprofloxacin is a recommended treatment for Shigella infections.
15 ella infection, 28.3 {CI, 7.2-112.2}; OR for Shigella infection, 14.5 {CI 1.5-141.0} or any recreatio
16 Abl and Arg are catalytically activated upon Shigella infection, accumulate at the site of bacterial
17 d. vaccination with IpaB and IpaD to prevent Shigella infection and support further studies in humans
18 or programmed cell death, is induced during Shigella infections and has been proposed to be a key ev
19 value of dysentery for the identification of Shigella infection, and the efficacy of antibiotics for
21 he human intestinal xenograft in response to shigella infection but failed to significantly alter tis
22 ith human intestine in vivo, we have studied shigella infection in human intestinal xenografts in sev
24 ction of MSD cases that were attributable to Shigella infection increased from 9.6% (n = 129) for cul
26 sentery for identification and management of Shigella infection might miss an opportunity to reduce S
27 g infection, the susceptibility to pulmonary Shigella infection of each of various mouse strains that
31 and suggest a novel approach to treatment of Shigella infections through inhibition of host cell sign
34 dysentery identified 1.9-85.9% of confirmed Shigella infections, with sensitivity decreasing over ti
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。